✦ LIBER ✦

PCN72 THE IMPACT OF INITIAL TREATMENT CHOICE AND DISEASE PROGRESSION ON THE ECONOMIC BURDEN OF PATIENTS AND THEIR CAREGIVERS—A LONGITUDINAL STUDY OF STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)

✍ Scribed by D Romanus; PJ Neumann; C Earle; MC Weinstein; JC Weeks

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study with paclitaxel and gem

✍ Ginopoulos, P.; Danikas, D.D.; Asimakopoulos, C.; Mastronikolis, N.S.; Kiriazis, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 84 KB

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

1434 POSTER Impact of KRAS Mutations (Kr

✍ S. Cros; L. Capdevila; E. Carcereny; T. Moran; A. Martinez; C. Buges; N. Pardo; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P-588 Biweekly docetaxel and vinorelbine

✍ Vázquez, S.; Villanueva, M.; Amenedo, M.; Firvida, J.; Lázaro, M.; Del Río, L.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

The Impact of Local and Regional Disease

✍ Daniel S. Higginson; Ronald C. Chen; Gregg Tracton; David E. Morris; Jan Halle; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 414 KB

817 Optimized schedule of gemcitabine (G

✍ F. Nelli; F. De Marinis; G. D'Auria; A. De Pasquale Ceratti; M.R. Migliorrino; G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 177 KB